Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
NL · NYSE · United States · Industrial Inorganic Chemicals
In shortNLI HOLDINGS, INC. is loss-making.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 6.7% | 39/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -23.9% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -10.0% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 7.77× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 13.92× | 100/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 7.45 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -25.4% | 0/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 13.8% | 60/100 |
| Operating margin volatility | 8.2% | 35/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -1.7% | 7/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 141 | 167 | 161 | 146 | 158 |
| Cost of revenue | 98 | 118 | 112 | 105 | 110 |
| Gross profit | 43 | 49 | 49 | 41 | 48 |
| Research & development | 0 | 0 | 0 | 0 | 0 |
| Selling, general & admin | 22 | 23 | 24 | 24 | 26 |
| Operating income | 10 | 14 | 14 | 38 | 11 |
| Interest expense | 1.1 | 0.9 | 0.7 | 0.5 | 0.8 |
| Pre-tax income | 61 | 39 | (6.4) | 83 | (51) |
| Income tax | 7.5 | 2.8 | (7) | 14 | (16) |
| Net income | 51 | 34 | (2.3) | 67 | (38) |
| Diluted EPS | $1.05 | $0.69 | −$0.05 | $1.38 | −$0.77 |
| Diluted shares (millions) | 49 | 49 | 49 | 49 | 49 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
7.45 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026